Christoffer Rahm, Principal Investigator of the Priotab project at Sweden’s Karolinska Institute, announces a breakthrough finding about the use of pharmaceuticals to reduce risk factors for some people with pedophilic disorder to commit child sexual abuse. The research paper in question has made available for open access, and can be downloaded here: Effect of Gonadotropin-Releasing Hormone Antagonist on Risk of …